论文部分内容阅读
目的:观察评价茵栀黄颗粒辅助治疗新生儿黄疸的临床疗效。方法:择选东莞市人民医院2015年6月至2016年6月所收治的60例新生儿黄疸患者作为研究对象,按随机数字表法分成观察组与对照组,两组各30例。其中,对照组患者采用临床常规治疗,观察组患者在常规治疗的基础上应用茵栀黄颗粒进行辅助治疗,对两组患者的临床治疗效果。结果:在住院时间上,观察组患者的住院天数要明显短于对照组患者,组间比较差异具有统计学意义(P<0.05);在治愈率上,两组患者相比差异,差异不具有统计学意义(P>0.05);在治疗前,观察组与对照组患者的血清胆红素水平指标相比无较大差异,此并异不具有统计学意义(P>0.05);在治疗后,观察组患者治疗第2天、第4天以及第7天的血清胆红素水平均要低于对照组患者,组间比较差异具有统计学意义(P<0.05)。结论:针对新生儿黄疸患者给予茵栀黄颗粒进行辅助治疗能进一步加快患者病情的好转速度,减低病死率及后遗症。
Objective: To observe and evaluate the clinical effect of Yinzhihuang granule in adjuvant treatment of neonatal jaundice. Methods: Sixty neonates with neonatal jaundice admitted from June 2015 to June 2016 in Dongguan People’s Hospital were selected as study subjects, and randomly divided into observation group and control group according to random number table method, with 30 cases in each group. Among them, the control group of patients with clinical routine treatment, the observation group patients on the basis of conventional treatment with Yinzhihuang particles for adjuvant therapy, the clinical efficacy of the two groups of patients. Results: The length of stay in the observation group was significantly shorter than that in the control group, the difference was statistically significant (P <0.05); in the cure rate, there was no difference between the two groups (P> 0.05). Before treatment, there was no significant difference in serum bilirubin level between observation group and control group (P> 0.05). After treatment . The serum bilirubin level in observation group was lower than that in control group on the second day, the fourth day and the seventh day after treatment. The difference between the two groups was statistically significant (P <0.05). Conclusion: The adjuvant treatment of Yinzhihuang granules for neonatal jaundice patients can further speed up the improvement of patient’s condition and reduce the mortality and sequelae.